Twinrix hepatitis vaccine often prescribed for travellers in short supply
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Digital Subscription
One year of digital access for only $205*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*First annual payment billed as $205.00 + GST for one year. This annual subscription will automatically renew at $233.00 + GST every 52 weeks (10% off the regular annual price of $259.35). Offer available to new and qualified returning subscribers only. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Your next Brandon Sun subscription payment will increase by $1.00 and you will be charged $17.95 plus GST for four weeks. After four weeks, your payment will increase to $24.95 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
Hey there, time traveller!
This article was published 10/01/2019 (2775 days ago), so information in it may no longer be current.
TORONTO – A Canada-wide shortage of the vaccine that protects against both hepatitis A and B could put a bit of a damper on Canadian sun-seekers’ travel plans this winter.
Twinrix is often prescribed for people heading to southern destinations where there is an increased risk of getting infected with the liver-attacking viruses, but the vaccine is in short-supply for both adults and children.
Hepatitis A is mostly spread through contaminated food and water. Most people infected recover completely with no permanent liver damage, but in some cases infection can lead to sudden liver failure.
Hepatitis B, a more serious disease primarily spread through sex, can lead to a chronic infection that increases the risk of cirrhosis, liver failure and liver cancer.
Manufacturer GlaxoSmithKline says vaccine production is a complex process that can take 10 to 26 months, and product shortages can occur due to unexpected demand, supply-chain disruptions or production issues.
GSK says Twinrix remains in limited supply, with ongoing efforts to restock the market. But the company anticipates disruptions may continue until availability of the vaccine stabilizes.